<code id='605F733A19'></code><style id='605F733A19'></style>
    • <acronym id='605F733A19'></acronym>
      <center id='605F733A19'><center id='605F733A19'><tfoot id='605F733A19'></tfoot></center><abbr id='605F733A19'><dir id='605F733A19'><tfoot id='605F733A19'></tfoot><noframes id='605F733A19'>

    • <optgroup id='605F733A19'><strike id='605F733A19'><sup id='605F733A19'></sup></strike><code id='605F733A19'></code></optgroup>
        1. <b id='605F733A19'><label id='605F733A19'><select id='605F733A19'><dt id='605F733A19'><span id='605F733A19'></span></dt></select></label></b><u id='605F733A19'></u>
          <i id='605F733A19'><strike id='605F733A19'><tt id='605F733A19'><pre id='605F733A19'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:1959
          the White House and the lawn in front of it shows behind a railing – coverage from STAT
          Mark Wilson/Getty Images

          President Biden’s executive order on artificial intelligence amounts to a giant course correction in health care. The actions taken in response could dramatically reshape how AI is used — and how much it costs — in areas from drug research to hospital care.

          The order, released in full detail late Monday, calls for two elements of AI oversight that are currently nonexistent in health care: a policy, or independent body, that would test and assure the quality of AI tools, and a “central tracking repository” to report clinical errors associated with the use of the technology.

          advertisement

          AI standards bodies in health care have previously pitched both ideas, but throwing the weight of the federal government behind them is more likely to bring them to fruition. Biden’s orders all require action before next fall’s election, a timeline designed to build momentum behind regulations that may be harder for a successor with different ideas to reverse.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          The Readout: Gilead, Bernie Sanders, and other pharma news
          The Readout: Gilead, Bernie Sanders, and other pharma news

          YichuanCao/SipaUSAWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechn

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Biden report: The neurospychology of memory and aging

          PresidentBidenEvanVucci/APWhatistherelationshipbetweenaging,memoryloss,andoverallcognition?That’sama